-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
EXCLUSIVE: This Cannabis Company Becomes The First To Have THC, CBD Licenses In Uruguay
EXCLUSIVE: This Cannabis Company Becomes The First To Have THC, CBD Licenses In Uruguay
YVY Life Sciences recently became the first company in Uruguay to receive both medical THC and CBD production licenses from the Institute for the Regulation and Control of Cannabis (IRCCA).
Why It Matters
YVY Life Sciences is one of the leading cannabis companies in Uruguay, offering unique experiences and high-quality natural products produced with an innovative and sustainable cultivation model.
The company's main operations are in Uruguay and it is currently launching business activities in Colombia and Argentina. YVY is part of the Terraflos family of companies, which also holds a stake in Blueberries Medical Corp (OTC:BBRRF).
What's Next
According to management, YVY will continue to develop its unique CBD cultivation model with La Armonia, a women's cooperative in Canalones, Uruguay. The partner farm will cultivate medical CBD flowers in greenhouses adhering to good agricultural practices (GACP).
Meanwhile, YVY has commenced its first medical THC cultivation cycle at its new property in Garzon. The cultivation, both in greenhouses and outdoors, will feature unique high-THC and mixed CBD/THC genetics, and be GACP certified as well.
"I'm super proud of our team for achieving this incredible milestone. As the first company in Uruguay to receive both medical CBD and THC cultivation licenses from IRCCA, we're ending 2021 on a big high and promise to continue innovating and pioneering the way forward in 2022," Kevin Nafte, co-founder and head of business development at YVY, told Benzinga.
Both CBD and THC cultivations will be dried and processed in a GMP-compliant facility with the goal of exporting the dried flowers and biomass for final consumption or extraction. Harvests are expected to take place in March and April 2022.
YVY Life Sciences recently became the first company in Uruguay to receive both medical THC and CBD production licenses from the Institute for the Regulation and Control of Cannabis (IRCCA).
依薇生命科學最近成為世界上第一家烏拉圭收到醫用THC和CBD的生產許可證都是從大麻調控研究所(IRCCA)獲得的。
Why It Matters
為什麼這很重要
YVY Life Sciences is one of the leading cannabis companies in Uruguay, offering unique experiences and high-quality natural products produced with an innovative and sustainable cultivation model.
依薇生命科學是烏拉圭領先的大麻公司,提供獨特的體驗和高質量的天然產品,以創新和可持續的種植模式生產。
The company's main operations are in Uruguay and it is currently launching business activities in Colombia and Argentina. YVY is part of the Terraflos family of companies, which also holds a stake in Blueberries Medical Corp (OTC:BBRRF).
該公司的主要業務在烏拉圭,目前正在哥倫比亞和阿根廷開展業務活動。Yvy是TerraFlos家族公司的一員,該家族還持有藍莓醫療公司(場外交易:BBRRF)。
What's Next
下一步是什麼?
According to management, YVY will continue to develop its unique CBD cultivation model with La Armonia, a women's cooperative in Canalones, Uruguay. The partner farm will cultivate medical CBD flowers in greenhouses adhering to good agricultural practices (GACP).
根據管理層的説法,Yvy將繼續發展其獨特的CBD培養模式,烏拉圭卡納洛內斯的婦女合作社La Armonia。合作農場將按照良好農業規範(GACP)在温室內培育藥用CBD花卉。
Meanwhile, YVY has commenced its first medical THC cultivation cycle at its new property in Garzon. The cultivation, both in greenhouses and outdoors, will feature unique high-THC and mixed CBD/THC genetics, and be GACP certified as well.
與此同時,Yvy已經在其位於加爾鬆的新物業開始了第一個醫用THC培養週期。温室和室外的栽培,將具有獨特的高THC和CBD/THC混合遺傳,並通過GACP認證。
"I'm super proud of our team for achieving this incredible milestone. As the first company in Uruguay to receive both medical CBD and THC cultivation licenses from IRCCA, we're ending 2021 on a big high and promise to continue innovating and pioneering the way forward in 2022," Kevin Nafte, co-founder and head of business development at YVY, told Benzinga.
“我為我們的團隊取得了這一令人難以置信的里程碑感到超級自豪。作為烏拉圭第一家同時獲得IRCCA頒發的醫用CBD和THC種植許可證的公司,我們將在2021年以一個很高的速度結束,並承諾在2022年繼續創新和開拓前進的道路。”凱文·納夫特, Yvy的聯合創始人兼業務發展主管告訴Benzinga.
Both CBD and THC cultivations will be dried and processed in a GMP-compliant facility with the goal of exporting the dried flowers and biomass for final consumption or extraction. Harvests are expected to take place in March and April 2022.
CBD和THC栽培將在符合GMP的設施中乾燥和加工,目標是出口乾燥的花卉和生物質用於最終消費或提取。收成預計將在2022年3月和4月進行。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧